Jumpei Taniguchi

15PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Molecular medicineMajor global burdens of diseasePacific Peoples and disability
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 04, 2026
Cost-effectiveness analysis of immune checkpoint inhibitors versus platinum-based doublet chemotherapy in the first-line treatment of advanced non-small-cell lung cancer with High PD-L1 expression in Japan.

Chanon Nusawat, So Sato, Jumpei Taniguchi

|Mar 03, 2026
Safety of Short-Term Trimethoprim-Sulfamethoxazole Use for Uncomplicated Cystitis: A Nationwide Retrospective Cohort Study.

Jumpei Taniguchi, Shotaro Aso, Hideo Yasunaga

|Feb 22, 2026
Risk of injury associated with the sedative potential of second-generation antihistamines: A nationwide retrospective cohort study.

Jumpei Taniguchi, Shotaro Aso, So Sato

|Oct 08, 2025
Mortality after broad- versus narrow-spectrum antibiotic treatment for patients with nursing and healthcare-associated pneumonia: A nationwide retrospective cohort study.

Jumpei Taniguchi, Shotaro Aso, Hiroki Matsui

|Jul 11, 2025
Association between preexisting long-term care needs and in-hospital mortality and long-term outcomes in older inpatients with pneumonia: A retrospective cohort study.

Jumpei Taniguchi, Hayato Yamana, Yuichiro Matsuo

|Jun 10, 2025
Outcomes of ceftriaxone 2 g versus 1 g daily in hospitalized patients with pneumonia: a nationwide retrospective cohort study.

Jumpei Taniguchi, Shotaro Aso, Hiroki Matsui

Pageof 3

Frequent Collaborators

3 joint publications

Shotaro Aso

3 joint publications

Hideo Yasunaga

2 joint publications

So Sato

1 joint publications

Hitoshi Sugawara